240 related articles for article (PubMed ID: 21737801)
1. Programmed death-1 pathway limits central nervous system inflammation and neurologic deficits in murine experimental stroke.
Ren X; Akiyoshi K; Vandenbark AA; Hurn PD; Offner H
Stroke; 2011 Sep; 42(9):2578-83. PubMed ID: 21737801
[TBL] [Abstract][Full Text] [Related]
2. Impairment of the programmed cell death-1 pathway increases atherosclerotic lesion development and inflammation.
Bu DX; Tarrio M; Maganto-Garcia E; Stavrakis G; Tajima G; Lederer J; Jarolim P; Freeman GJ; Sharpe AH; Lichtman AH
Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1100-7. PubMed ID: 21393583
[TBL] [Abstract][Full Text] [Related]
3. PD-L1 enhances CNS inflammation and infarct volume following experimental stroke in mice in opposition to PD-1.
Bodhankar S; Chen Y; Vandenbark AA; Murphy SJ; Offner H
J Neuroinflammation; 2013 Sep; 10():111. PubMed ID: 24015822
[TBL] [Abstract][Full Text] [Related]
4. The PD-1/PD-L costimulatory pathway critically affects host resistance to the pathogenic fungus Histoplasma capsulatum.
Lázár-Molnár E; Gácser A; Freeman GJ; Almo SC; Nathenson SG; Nosanchuk JD
Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2658-63. PubMed ID: 18268348
[TBL] [Abstract][Full Text] [Related]
5. CNS expression of B7-H1 regulates pro-inflammatory cytokine production and alters severity of Theiler's virus-induced demyelinating disease.
Duncan DS; Miller SD
PLoS One; 2011 Apr; 6(4):e18548. PubMed ID: 21494618
[TBL] [Abstract][Full Text] [Related]
6. Expression of programmed death 1 ligands by murine T cells and APC.
Yamazaki T; Akiba H; Iwai H; Matsuda H; Aoki M; Tanno Y; Shin T; Tsuchiya H; Pardoll DM; Okumura K; Azuma M; Yagita H
J Immunol; 2002 Nov; 169(10):5538-45. PubMed ID: 12421930
[TBL] [Abstract][Full Text] [Related]
7. Constitutive neuronal expression of the immune regulator, programmed death 1 (PD-1), identified during experimental autoimmune uveitis.
Chen L; Pai V; Levinson R; Sharpe AH; Freeman GJ; Braun J; Gordon LK
Ocul Immunol Inflamm; 2009; 17(1):47-55. PubMed ID: 19294574
[TBL] [Abstract][Full Text] [Related]
8. Forced expression of programmed death-1 gene on T cell decreased the incidence of type 1 diabetes.
Won TJ; Jung YJ; Kwon SJ; Lee YJ; Lee DI; Min H; Park ES; Joo SS; Hwang KW
Arch Pharm Res; 2010 Nov; 33(11):1825-33. PubMed ID: 21116786
[TBL] [Abstract][Full Text] [Related]
9. B7-H1-induced apoptosis as a mechanism of immune privilege of corneal allografts.
Hori J; Wang M; Miyashita M; Tanemoto K; Takahashi H; Takemori T; Okumura K; Yagita H; Azuma M
J Immunol; 2006 Nov; 177(9):5928-35. PubMed ID: 17056517
[TBL] [Abstract][Full Text] [Related]
10. Target-dependent B7-H1 regulation contributes to clearance of central nervous system infection and dampens morbidity.
Phares TW; Ramakrishna C; Parra GI; Epstein A; Chen L; Atkinson R; Stohlman SA; Bergmann CC
J Immunol; 2009 May; 182(9):5430-8. PubMed ID: 19380790
[TBL] [Abstract][Full Text] [Related]
11. Partial restoration of T-cell function in aged mice by in vitro blockade of the PD-1/ PD-L1 pathway.
Lages CS; Lewkowich I; Sproles A; Wills-Karp M; Chougnet C
Aging Cell; 2010 Oct; 9(5):785-98. PubMed ID: 20653631
[TBL] [Abstract][Full Text] [Related]
12. Blocking programmed death-1 ligand-PD-1 interactions by local gene therapy results in enhancement of antitumor effect of secondary lymphoid tissue chemokine.
He YF; Zhang GM; Wang XH; Zhang H; Yuan Y; Li D; Feng ZH
J Immunol; 2004 Oct; 173(8):4919-28. PubMed ID: 15470033
[TBL] [Abstract][Full Text] [Related]
13. Regulatory B cells limit CNS inflammation and neurologic deficits in murine experimental stroke.
Ren X; Akiyoshi K; Dziennis S; Vandenbark AA; Herson PS; Hurn PD; Offner H
J Neurosci; 2011 Jun; 31(23):8556-63. PubMed ID: 21653859
[TBL] [Abstract][Full Text] [Related]
14. Differential binding properties of B7-H1 and B7-DC to programmed death-1.
Youngnak P; Kozono Y; Kozono H; Iwai H; Otsuki N; Jin H; Omura K; Yagita H; Pardoll DM; Chen L; Azuma M
Biochem Biophys Res Commun; 2003 Aug; 307(3):672-7. PubMed ID: 12893276
[TBL] [Abstract][Full Text] [Related]
15. CX3CR1 deficiency suppresses activation and neurotoxicity of microglia/macrophage in experimental ischemic stroke.
Tang Z; Gan Y; Liu Q; Yin JX; Liu Q; Shi J; Shi FD
J Neuroinflammation; 2014 Feb; 11():26. PubMed ID: 24490760
[TBL] [Abstract][Full Text] [Related]
16. Role of the immune modulator programmed cell death-1 during development and apoptosis of mouse retinal ganglion cells.
Chen L; Sham CW; Chan AM; Francisco LM; Wu Y; Mareninov S; Sharpe AH; Freeman GJ; Yang XJ; Braun J; Gordon LK
Invest Ophthalmol Vis Sci; 2009 Oct; 50(10):4941-8. PubMed ID: 19420345
[TBL] [Abstract][Full Text] [Related]
17. Blockade of B7-H1 suppresses the development of chronic intestinal inflammation.
Kanai T; Totsuka T; Uraushihara K; Makita S; Nakamura T; Koganei K; Fukushima T; Akiba H; Yagita H; Okumura K; Machida U; Iwai H; Azuma M; Chen L; Watanabe M
J Immunol; 2003 Oct; 171(8):4156-63. PubMed ID: 14530338
[TBL] [Abstract][Full Text] [Related]
18. Programmed death ligand 1 regulates a critical checkpoint for autoimmune myocarditis and pneumonitis in MRL mice.
Lucas JA; Menke J; Rabacal WA; Schoen FJ; Sharpe AH; Kelley VR
J Immunol; 2008 Aug; 181(4):2513-21. PubMed ID: 18684942
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues.
Ishida M; Iwai Y; Tanaka Y; Okazaki T; Freeman GJ; Minato N; Honjo T
Immunol Lett; 2002 Oct; 84(1):57-62. PubMed ID: 12161284
[TBL] [Abstract][Full Text] [Related]
20. Proatherogenic immune responses are regulated by the PD-1/PD-L pathway in mice.
Gotsman I; Grabie N; Dacosta R; Sukhova G; Sharpe A; Lichtman AH
J Clin Invest; 2007 Oct; 117(10):2974-82. PubMed ID: 17853943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
